Gel for the treatment of wounds


(57) Abstract:

The invention relates to medicine. To reduce treatment time RAS features gel on gelatin-glycerol-based as a medicinal product containing 0.1 to 0.6% integrated product isolated from the cytoplasm of Staphylococcus aureus, having a peculiar effect on the pathogen. Selected optimum ratio of therapeutic doses and gel bases facilitate the active contact of the drug with wound tissue, which provides faster healing of wounds and reduces the treatment time. table 1.

The invention relates to medicine and veterinary medicine, and in particular to methods of treatment of wounds.

Known ointment containing drug gentamicin sulfate ointment and a basis in the ratio (grams) of 0.1:99,9 respectively, used for the treatment of pyodermia (M. D. Mashkovsky "Drugs", M,Medicine, 1993, so 2, page 288) prototype.

However, the known ointment has a nonspecific effect and requires long-term use.

The aim of the invention is the reduction of treatment time of pyodermia.

This goal is achieved by the use of "Sonatina" with specificamente drug use daily microbial culture, grown on agar of Hottinger. To obtain the "Tomatina" microbial mass of Staphylococcus containing 1 ml 250 billion microbial cells are subjected to degradation in the mechanical disintegrator (L-17) using the beads Bollotini N 11. After removal of intact microbial cells and cell walls by centrifugation (at 8000-10000 rpm, 30 minutes) get the cytoplasmic fraction. Electron microscopic examination shows complete absence of intact cells and cell walls in the cytoplasm.

The chemical composition of the cytoplasm: protein (58-60%),nucleic acids (11-13%), reducing sugar (11-13%), lipids (9-10%). In immunoelectrophoresis cytoplasm forms with homologous serum 7 bands of precipitation, electrophoresis in polyacrylamide gel is divided into 19 components.

Example 1. "Somethin" separated from the cytoplasm sequentially by acid precipitation at pH 3.5, followed by presidenial at pH 4.5. To remove protein impurities are trypsinization for 4 hours, allowing you to remove from the drug for more than 60% protein. Chemical composition Sonatina": protein (40-45%), nucleic acids (30-34%), reducing sugar (13-17%) and lipids (5-6%). In immunoelectrophoresis "Somethin" on the SJ 9 components. The drug cialiswhat against saline for 24 hours (d=0,045 mm, Visking dialysis tubing "SERVA"), and then freeze-dried. Gelfiltration drug on Sephadex g-75 determines that the output curve has two asymmetric peak, and the peak fraction 1 is identical to the original trypsinization fraction chemical composition, immunogenicity and serological activity. Fraction 2 peak poorly immunogenic and serologically inactive.

Thus "Somethin composition is complex, including substance nucleic nature, protein, polysaccharides and lipids, drug soluble in physiological solution pH 7,0-7,8.

Research on animals shows that the immunity created "Sonatina", is peculiar, because it creates a protection only against Staphylococcus. The basic mechanism of the immune system caused by the activation of intracellular digestion phagocytosing staphylococci. In the abdominal cavity immunized and infected animals there is a rapid influx of leukocytes and continuous decrease in the number of living microbes. Along with this process Somethin" is an activator of T-helper cells, which enhance the synthesis of specific antibodies.

ogie and hygienic regulation of biopreparations (NICTSP). Installed the complete absence of sensibilizatsii body substance "Sonatina" when applied to skin.

Example 2. Gel for the treatment of wounds produced as follows: gelatin soaked in distilled water, heated to dissolve, and after cooling to a temperature equal to 40oC add "Somethin" with glycerin and boric acid.

To prepare 100 g of gel containing 0.1-0.6% of "Sonatina", take the ingredients in the following quantities (g):

"Somethin" is 0.1 and-0.6

Glycerin - 25,0

Gelatin - 10,0

Boric acid and 2.0

Distilled water to 100.0

A method of treating wounds using "Sonatina" studied in experiments on animals. Use of adult dogs of both sexes.

Example 3. Under observation taken 5 animal groups in three dogs in each breed: German shepherd, Cocker Spaniel, French bulldog, great Dane, Neapolitan mastin, Royal poodle). Dogs three groups receiving treatment with a gel containing "Somethin in concentrations 0,1,0,3 and 0.6%. The fourth group of control (animals put gel base without "Sonatina"). Dogs of the fifth group to compare the effectiveness of the treatment applied is 0.1% gentamitsinovoy ointment. Srednes the s S. aureus, S. epedermidis, S. intermedius, Str.pyogenes

After debridement grease gel containing "Somethin in concentrations of 0.1, 0.3 and 0.6 percent, dried 5-7 minutes and apply a sterile dressing. Ligation spend every day. The results of the treatment of wounds in the table.

As can be seen in the table, treatment with a gel containing different concentrations of "Sonatina" leads to positive effect. Redness and swelling in the lesions reduced by treatment with 0.1% Satinover gel next day, when treating with 0.3% gel in 0.5 days and 0.6% gel through 0.6 days, and 0,1% gentamitsinovoy ointment on the 4th day. Purification of purulent-necrotic tissue occurs in the treatment of 0.1% Satinover gel on the 5th day, 0.3% and 0.6% gel on the 4th day, and 0,1% gentamitsinovoy ointment on the 7th day. The appearance of granulation observed in the treatment with 0.1% Satinover gel on the day 3, 0.3% and 0.6% gel on the 2nd day. Treatment with 0.1% gentamitsinovoy ointment leads to the appearance of granulations on the 4th day. Filling the wounds with granulation occurs on the 5th day for lubrication of 0.1% Satinover gel and after 4 days in the treatment of 0.3% and 0.6% gel. In the treatment of 0.1% gentamitsinovoy ointment granulation tissue fills the wound n is on the 5th day, and of 0.1% gentamitsinovoy ointment on the 8th day. Wound healing is observed on the 22nd day when lubricating RAS 0,1% Satinover gel, on the 20th day in the treatment of 0,3-0,6% gel and on 28th day of treatment with 0.1% gentamitsinovoy ointment.

Dogs in the control group, which is applied on the affected skin gel base without "Sonatina", therapeutic effect is not observed.

The treatment results show the advantages of the proposed method of treatment of wounds gel containing 0.1-0.6% of "Sonatina", compared with the 0.1% gentamitsinovoy ointment. The treatment of purulent wounds of the proposed method (gel containing 0.1-0.6% of "Sonatina") is more effective than treatment with 0.1% gentamitsinovoy ointment, as the treatment time is reduced on average 8 days.

Thus, therapeutic effect of the gel is achieved due to the specific impact Sonatina" on the protective properties of the wounded tissue. Optimal ratio of a therapeutic dose and a gel base. The proposed gel Foundation promotes the active contact of the drug with the wounded tissues, which speeds up the healing of wounds.

We offer gel containing "Somethin", has no side effects on the body of the dog.

Gel for the treatment of wounds, comprising l is the integrated product isolated from the cytoplasm of Staphylococcus aureus, consisting of nucleic acid (30 - 34%), protein (40 - 45%), reducing sugars (13 - 17%) and lipids (5 - 6%), and gel-based contains glycerin, gelatin, boric acid and distilled water in the following proportions of components:

The integrated product isolated from the cytoplasm of Staphylococcus aureus - 0,1 - 0,6

Glycerin - 25,0

Gelatin - 10,0

Boric acid and 2.0

Distilled water Up to 100.0


Same patents:
The invention relates to medicine applies balm-ointment for the treatment of deep and extensive burns and infected wounds and ulcers

The invention relates to medicine and for the development of new drugs for the treatment and prevention of viral diseases

The invention relates to medicine, namely to create ointments herbal treatment for psoriasis

The invention relates to medicine and the pharmaceutical industry and relates to a means of stimulating the reparative processes in tissues
The invention relates to the field of medicine
The invention relates to food processing and pharmaceutical industries

The invention relates to iododerma biologically active compositions containing iodine and halides of nitrogenous bases of the formula I, where the values of the radicals a, b, C, R, X and m are specified in the claims
The invention relates to medicine, in particular to composite medicines used for the treatment of skin diseases

FIELD: agriculture, animal husbandry, organic chemistry.

SUBSTANCE: antiseptic ointment comprises cationic surface-active substance, lower glycols, polyethylene glycols, water and ethylene glycol monophenolic ester and higher polyethylene glycols taken in the definite ratio of components. As cationic surface-active substance ointment comprises N-alkyl-N-alkoxycarbonylmethylhexahydroazipinium chloride or alkyldimethylbenzylammonium chloride, or cetylpyridinium bromide, or cetylpyridinium chloride, or 1,2-ethylenebis-(N-methylcarbdecyloxymethyl)ammonium dichloride, or ethylhexadecyldimethylammonium chloride, or chlorhexidine; as lower glycol ointment comprises 1,2-propylene glycol or polyethylene glycol-300, or polyethylene glycol-400; as higher polyethylene glycol ointment comprises polyethylene glycol-1500 or polyethylene glycol-3000, or polyethylene glycol-4000, or polyethylene glycol-6000. Ointment elicits the high antibacterial activity, broad spectrum of bactericidal effect and low irritating effect with respect to udder skin. Invention can be used for sanitary-hygienic treatment of udder of lactating cows for prophylaxis and rapid healing external damages of udder and nipples (arising cracks), prophylaxis of mastitis, enhancing milk purity by microbiological indices.

EFFECT: valuable antiseptic properties of ointment.

2 cl, 1 tbl, 22 ex

FIELD: medicine.

SUBSTANCE: the present innovation deals with curative ointments of antiphlogistic and wound-healing action and could be applied for treating hemorrhoid, burns, bruises, fractures, wounds, chronic bronchitis, polyarthritis, periarthritis, radiculitis, trophic ulcer and psoriasis. Three variants of ointments have been suggested. They contain oily extract of plant components and, also, honey, mumiye, propolis and bear oil. This innovation enables to widen the assortment of ointments of antiphlogistic and wound-healing and the range of curative action upon a body.

EFFECT: higher efficiency of application.

3 cl, 11 ex

FIELD: pharmaceuticals.

SUBSTANCE: invention provides topical blood circulation improving remedy containing simultaneously nitroglycerine and aminophylline. Remedy can be provided in the form of emulsion, gel, or ointment, which are administered 1-2 times a day.

EFFECT: strengthened blood circulation activation effect, which is prolonged to 24 hours.

5 cl, 9 ex

"antipsoriaz" cream // 2246935

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to developing medicaments in the form of ointment based on vegetable components and designed, in particular, to treat psoriasis as well as fungus diseases and can also be used in cosmetology. Psoriasis treatment cream includes water extracts of bur-marigold (Bidens tvipartita), white birch leaves (Betula alba L), greater celandine (Chelidonium majus), calendula (Calendula officanalis L), cudweed (Gnphalium uliginosum L), medical vaseline, lanolin, camphor, linseed oil, and medical solid oil at specified proportions of components.

EFFECT: increased treatment efficiency, avoided use of chemical additives, and prolonged shelf time.

FIELD: pharmaceutical industry.

SUBSTANCE: invention provides antiinflammatory and wound-healing ointment based on natural components, which invention, along with vegetable oils, may further contain ursine fat, ursine bile, propolis, lanoline, honey, and mummified guano. Variously formulated ointments can be used for treating hemorrhoids, burns, antritis, post-stroke condition, gunshot and stab-punctured wounds, trophic ulcer, postoperative fistula, oophoritis, diabetic microangiopathy of lower extremities, as well as papillomas, birthmarks, seborrhea, and psoriasis.

EFFECT: expanded therapeutical possibilities.

6 cl, 17 ex

Acyzol-based agent // 2247558

FIELD: pharmaceutical industry.

SUBSTANCE: invention provides novel nontoxic and highly bioavailable acyzol-based agent characterized by high activity in treatment of skin diseases, in restoration of structural skin processes, suppression of nevus pigmentosis, and flattening of folds.

EFFECT: increased assortment of skin-healing drugs.

7 cl, 4 ex

FIELD: organic synthesis.

SUBSTANCE: invention provides a method for preparing water/glycerol complex of (2,3-dihydroxypropyl) ortho-titanate hydrochloride (chloride) having symbolic name "Ephtiderm", which is depicted by following empirical formula: Method consists in that glycerol is mixed with butyl ortho-titanate at molar ratio 12:1, whereupon butanol is distilled off in vacuum, residue is treated with water and aqueous hydrochloric acid to form reaction mass with pH 2.2-3.0, which is heated in vacuum. Method is characterized by that glycerol is mixed with low-grade butyl ortho-titanate and chloroform, reaction mass during the synthesis is maintained at temperature up to 100°C in vacuum 40-200 mm Hg, while chloroform is added at 40-50°C in amount corresponding to 1 L chloroform per 2 L low-grade butyl ortho-titanate.

EFFECT: reduced expenses due to use of low-grade butyl ortho-titanate and simplified technology.

1 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: the present innovation deals with medicinal preparation as an ointment for treating skin burns. The suggested preparation contains bee wax, propolis and vegetable oil. Thus, application of initially intact propolis and bee wax in combination with fatty foundation as vegetable oil enables to cheapen and simplify the technique to prepare the preparation, and optimally matched consistence provides prolonged safety of the preparation and accelerates healing of skin burns.

EFFECT: higher efficiency of therapy.

1 cl, 2 ex

FIELD: medicine, gynecology, pharmacology, pharmaceutical industry.

SUBSTANCE: invention proposes a preparation that comprises bacterial mass of live microorganisms as an active component, protecting medium and fat base. The preparation comprises lactobacilli as bacterial mass and one or some eubiotic microorganisms taken among the following group: bifidobacteria, streptococci and lactococci taken in the amount per a single dose. Also, the preparation comprises additionally an acceptable sorbent and a biologically active supplement. Also, invention relates to a method for preparing this preparation that involves preparing firstly lactobacilli bacterial mass and one or some genus of eubiotic microorganisms taken among the following group: bifidobacteria, streptococci and lactococci. Then the prepared bacterial mass of microorganisms is immobilized on sorbent used in medicine in its ratio to bacterial mass of microorganisms = (9-1):(1-9) followed by addition of the protecting medium and biologically active supplement to formed mass in the necessary amount. Also, invention describes a method for prophylaxis and treatment of bacterial vaginitis that involves intravaginal administration of the preparation described above in the amount 1-3 doses, 1-3 times per 24 h. The treatment course is prescribed individually. Invention provides expanding assortment of agents used for treatment of bacterial vaginitis. Invention can be used in obstetric-gynecological practice.

EFFECT: improved method for vaginitis treatment, valuable medicinal properties of preparation.

13 cl, 4 tbl, 1 ex

FIELD: pharmaceutics.

SUBSTANCE: the suggested composition has got viscosity being below of about 15000 cP and pH being approximately 3.0-9.0 for treating human skin diseases. He suggested composition consists of (a) therapeutically efficient quantity of, at least, one compound being useful in treating the above-mentioned disease; (b) pharmaceutically acceptable, partially bound polymer of polyacrylic acid being compatible with the compound; (c) not obligatory, a solvent being mixed with water, (d) not obligatory, a conserving agent, (e) not obligatory, a component of butyric phase and acceptable surface-active substance, and (f) water. The suggested composition is useful to treat inflammatory skin disease, acne or acne erythematosa. The composition of low viscosity has got its advantage in the fact that it is applied more accurately when in contact with a container that doses the composition in the form of drops.

EFFECT: higher efficiency of application.

23 cl, 15 ex, 19 tbl